Jolimark Holdings Limited Issues Profit Warning for FY2025

Key Highlights

• Expected Net Loss: Jolimark Holdings Limited forecasts a net loss in the range of RMB 48 million to RMB 55 million for the financial year ending 31 December 2025. This represents a slight improvement compared to the loss of approximately RMB 60.262 million reported for the previous year.
• Primary Causes of Loss:
  • Lower market demand for printers, attributed to the ongoing shift towards electronic invoicing solutions.
  • Medical equipment products remain in the promotional stage, not yet contributing significant revenue.
  • Provision for asset impairment has further impacted the bottom line.
• Financial Results Status: The figures are based on a preliminary review of unaudited consolidated management accounts. The audited final results for the year ended 31 December 2025 are expected to be announced before the end of March 2026.

Important Information for Shareholders and Investors

• Price Sensitive Information: This profit warning is classified as inside information under Hong Kong’s Securities and Futures Ordinance, and is likely to be price-sensitive. The anticipated loss, even though an improvement over the previous year, reflects ongoing operational challenges and may impact investor sentiment and the Company’s share price.
• Uncertainty Remains: The announcement stresses that the information provided is based on preliminary assessments and unaudited figures. Actual audited results may differ from these estimates.
• Caution Advised: Shareholders and potential investors are strongly advised to exercise caution when dealing in the Company’s securities until the final results are released.
• Leadership & Governance: The board currently consists of executive directors Mr. Au Pak Yin and Mr. Au Kwok Lun, non-executive director Mr. Ou Guo Liang, and independent non-executive directors Ms. Kan Lai Kuen, Alice, Mr. Sun Po Yuen, and Mr. Yeung Kwok Keung.
• Timeline: Final audited results are expected before the end of March 2026.

Detailed Overview

On 16 March 2026, Jolimark Holdings Limited issued a profit warning to inform shareholders and potential investors of an expected net loss for the year ended 31 December 2025. The projected loss, ranging between RMB 48 million and RMB 55 million, is primarily due to a continuous decline in demand for printers—a result of increasing adoption of electronic invoicing. Additionally, the Company’s foray into medical equipment has yet to yield significant returns as the products are still in their early promotional phases. Furthermore, the Company has made provisions for asset impairment, negatively affecting its profitability this year.

Despite the loss being smaller than last year’s, the ongoing challenging market conditions and the Company’s transition efforts signal potential operational risks and uncertainties. The announcement serves as a formal warning under the regulatory frameworks of the Hong Kong Stock Exchange and the Securities and Futures Ordinance, signaling to investors that the Group’s performance remains under pressure.

The Board emphasizes that these numbers are preliminary and unaudited, and the actual results may vary. Final audited results will be released before the end of March 2026, and all stakeholders are urged to remain cautious.

Conclusion

The profit warning issued by Jolimark Holdings Limited is a material development that could influence the Company’s share price. Investors and shareholders should monitor the situation closely, especially as the Company continues to navigate industry headwinds and awaits the final audited results.

Disclaimer: The information contained in this article is derived from Jolimark Holdings Limited’s official announcement and is intended for informational purposes only. The financial figures are preliminary and unaudited, and actual results may differ. Investors are advised to exercise caution and consult professional advisors before making any investment decisions. This article does not constitute investment advice or a recommendation to buy or sell any securities.

View JOLIMARK Historical chart here